Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Joel Lusman’s Lusman Capital Filed 7.85% Passive Stake in $INSW

Joel Lusman’s Lusman Capital filed on November 9th for its 7.85% passive stake in Insweb Corp (INSW). According to the 13G filing, Lusman Capital now has 450 thousand shares in INSW. INSW experienced large slumps in the third quarter, but the stock surged by 40% on October 11th when Bankrate, Inc. announced to acquire the Insurance Lead Generation and Marketing assets of InsWeb Corp for $65 million. Now INSW breaks even in 2011, and is priced at $8.25.

Jim Simons’ Renaissance Technologies was also bullish about INSW according to its portfolio in the second quarter. Renaissance Technologies took 62 thousand shares in the stock, slightly down by 1% from Q1.


Lusman Capital is a privately owned investment firm categorized under Financial Advisory Services. The firm is based in New York City, NY.

According to Yahoo! Finance, InsWeb Corporation “operates an online insurance marketplace that electronically matches consumers and providers of automobile, property, health, term life, and small business insurance in the United States and District of Columbia. Its marketplace enables consumers to research insurance-related topics, search for, analyze and compare insurance products, and request quotes for coverage for insurance products. The company was founded in 1995 and is headquartered in Gold River, California.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!